Integra LifeSciences Holdings Corporation (IART) News
Filter IART News Items
IART News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
IART News Highlights
- For IART, its 30 day story count is now at 5.
- Over the past 9 days, the trend for IART's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- DEC, DUO and EAR are the most mentioned tickers in articles about IART.
Latest IART News From Around the Web
Below are the latest news stories about INTEGRA LIFESCIENCES HOLDINGS CORP that investors may wish to consider to help them evaluate IART as an investment opportunity.
Integra (IART) to Advance ENT Division With New Buyout DealIntegra (IART) will be among the top suppliers of ENT products and technologies following the Acclarent acquisition. |
Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent®The acquisition will become part of Integra’s Codman Specialty Surgical (CSS) division. The ear, nose and throat (ENT) category is a key area of strategic interest and highly complementary to the neurosurgery segment.Provides a unique opportunity to build scale and capture a leadership position in the attractive ENT device segment with Acclarent’s established commercial scale, strong brand recognition, differentiated portfolio, and robust innovation pipeline. Generates shareholder value; transac |
Integra to buy J&J’s Acclarent for $275MIntegra said the purchase, which includes a portfolio of balloon dilation products for the sinuses and eustachian tube, would make it a market leader in ENT procedures. |
Integra LifeSciences Appoints Jeff Graves, Ph.D., to Board of DirectorsJeff Graves Integra LifeSciences Appoints Jeff Graves, Ph.D., to Board of Directors PRINCETON, N.J., Dec. 12, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Jeff Graves, Ph.D., president and chief executive officer of 3D Systems Corporation, was appointed to the company’s board of directors, effective immediately. With the appointment of Dr. Graves, Integra has added four new directors since 202 |
Integra Gains From New Product Launches, Mounting Costs AilIntegra expands the international reach of the CUSA platform and registers DuraGen, DuraSeal, Mayfield and Duo LED lighting in the EMEA and Latin America. |
Why Is Glaukos (GKOS) Down 0.4% Since Last Earnings Report?Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Why Is Integra (IART) Up 10.2% Since Last Earnings Report?Integra (IART) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Why Integra LifeSciences Holdings Corporation (NASDAQ:IART) Could Be Worth WatchingIntegra LifeSciences Holdings Corporation ( NASDAQ:IART ), is not the largest company out there, but it saw a decent... |
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2023 Earnings Call TranscriptIntegra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2023 Earnings Call Transcript October 25, 2023 Integra LifeSciences Holdings Corporation misses on earnings expectations. Reported EPS is $0.76 EPS, expectations were $0.78. Operator: Good day, and thank you for standing by. Welcome to the Integra LifeSciences’ Third Quarter 2023 Financial Results Conference Call. At this time, all participants […] |
Integra's (IART) Q3 Earnings Miss Estimates, 2023 View CutThe impact of lost revenues and an increase in the return provision related to the Boston product recall dent Integra's (IART) Q3 revenues. |